Dr Reddy’s Laboratories announced a licencing agreement with US-based Slayback Pharma to obtain rights to Brimonidine Tartrate Ophthalmic Solution 0.025 percent that reduces eye redness.
Indian pharmaceutical exports increased by 8% in the first quarter of the current fiscal year to reach USD 6.26 billion, and officials anticipate a 10% increase by year’s end.
USFDA has completed a pre-approval examination at the formulations manufacturing facility of Casper Pharma Private Limited, which is a fully owned subsidiary of Suven Pharmaceuticals Limited in Hyderabad, India.
Bristol Myers Squibb announced that a trial examining the combination of its two cancer medications, Yervoy and top-selling cancer therapy Opdivo, failed to achieve the primary objective of treating localized kidney cancer.
Recently, Manish Choksi was appointed as an independent director by the board of directors of Torrent Pharma, subject to the approval of the company’s shareholders, for a term of five years starting on July 29, 22. He is unrelated to any other Company Director.
Department of Pharmaceuticals (DoP) will have nine products under the fermentation-based specialty products and 24 products under the chemicals synthesis route, as opposed to 10 and 23 products respectively.
Sun Pharmaceutical & Industries, a significant
pharmaceutical company with annual sales of
over Rs. 38,200 crore, reported consolidated net
profit of Rs. 2,061 crore for the first quarter
ending in June 2022 as opposed to Rs. 1,444
crore for the same period in the previous year.
If you don’t already have an account click the button below to create your account.Create New Account